Astragalus glycyphy, European meadowsweet, blood-red hawthorn, low cudweed, ziziphora.
Evening compositionAstragalus glycyphy, European meadowsweet, blood-red hawthorn, low cudweed, ziziphora, quinquelobate motherwort.
Isn't medicine (Not a medicinal product)
The products meet/satisfy the established requirements of the Eurasian Economic Union (EAEU)
Infusions and brews from astragalus extend coronary vessels and exercise a hypotensive, cardioactive and apparent calming effect.
Meadowsweet improves blood microcirculation and metabolic processes in tissues.
Preparations from hawthorn extend coronary vessels and cerebral vessels selectively, reduce excitability of nervous system, enhance oxygen supply of heart and cerebrum, improve metabolism, normalize cardiac rhythm, sound and general condition, promote reduction of cholesterol level in blood.
Cudweed provides reduction of arterial blood pressure.
Ziziphora preparations possess sedative action. They promote reduction of arterial blood pressure. They are used as an additional preventive drug in case of heart attacks and strokes.
Motherwort is widely applied as calming means in case of increased neural irritability, at early stages of hypertension, neuralgia and heart weakness.
Prevention of cerebrovascular disturbances. Prevention of coronary circulation disorders.Rehabilitation actions in post-infarction and post-stroke periods.
